Endocrine News Podcast Episode 95: Environmental Impact on Early Female Puberty

Release Date: December 4, 2024
Host: Aaron Lohr
Guest: Dr. Natalie Schall, Lasker Clinical Research Scholar, Principal Investigator at NIH’s National Institute of Environmental Health Sciences
Topic: Could environmental chemicals trigger early female puberty? Latest research and key findings.

Episode Overview

This episode delves into the growing body of research on the effects of environmental compounds—specifically endocrine-disrupting chemicals—on the timing of puberty in girls. Host Aaron Lohr speaks with Dr. Natalie Schall about her team’s new study, which examines how certain environmental compounds may activate hormonal pathways in the brain, potentially leading to earlier onset of puberty.

Key Discussion Points & Insights

1. The Alarming Trend of Earlier Female Puberty

[01:11] Dr. Schall:

• There is a documented trend toward earlier puberty in girls, seen in earlier breast development and menarche (first period).
• The change is relatively rapid, suggesting environmental rather than genetic causes.
• “It’s less clear if the same thing is happening in boys, but it’s happening at a relatively rapid pace, which suggests that it’s not related to genetic effects, but is caused by something in the environment.” (01:26)

2. Environmental Chemicals as Endocrine Disruptors

[01:48] Dr. Schall:

• Many environmental compounds are endocrine disruptors; they can activate or inhibit parts of the endocrine system by binding to hormone receptors (estrogen, androgen, etc.).
• Such exposures can alter hormone-driven processes like puberty.

3. Focus on Brain Pathways: Kisspeptin and GnRH Receptors

[02:20] Dr. Schall:

• Most research has targeted estrogen/androgen receptors; Dr. Schall’s study focused on kisspeptin and gonadotropin-releasing hormone (GnRH) receptors, central players in initiating puberty.
• “Puberty doesn’t start at the level of the breast. It starts in the brain and the hypothalamus.” (02:37)

4. Methodology: High-Throughput Screening of Environmental Chemicals

[02:58] Dr. Schall:

• Collaboration with toxicologists at NIH’s NCATS (National Center for Advancing Translational Sciences).
• Used the TOX21 10K library—10,000 common environmental compounds.
• Screened compounds for activity on human kisspeptin and GnRH receptors using a cell line, then validated findings in human neurons and zebrafish.

5. Noteworthy Findings and Surprising Results

[04:35] Dr. Schall:

• All findings were novel as these receptors haven’t been scrutinized for environmental activation before.
• The most striking discovery: musk ambrette, a fragrance compound in cosmetics, significantly activated the kisspeptin receptor.
• Cholinergic agonists also activated the GnRH receptor, but children’s exposure to these is less common.
• “[The] most interesting finding was this compound called musk ambrette, which is known to be in fragrances and cosmetic products. And we found that that activated this kisspeptin receptor.” (04:45)

6. Implications for Everyday Exposure

[05:36] Dr. Schall:

• Musk ambrette may be widespread in consumer products, though actual exposure levels in children are currently unknown.
• “You can kind of buy whatever you want off Amazon and no one is really checking what’s in there... We really don’t know, and we don’t know in our children in the US are they being exposed to this compound in cosmetic products or not? And that’s something we need to study next.” (05:41)

7. Dose and Hormonal Effects: It’s Not Always About Quantity

[06:34] Dr. Schall:

• Endocrine-disrupting chemicals can have effects at low doses, and sometimes it’s not the duration but the fluctuation of exposure that triggers hormonal changes.
• Example: In congenital adrenal hyperplasia, normalization (not excess) of hormone levels can sometimes trigger puberty onset.
• “It could be having an exposure and then the withdrawal of that exposure is actually what can trigger the system.” (06:46)

8. Take-Home Message and Research Impact

[07:26] Dr. Schall:

• The study establishes a promising pipeline for screening and validating environmental effects on brain-puberty pathways.
• “It sets up a pipeline that other people could follow…high-throughput screen in a human cell line, validating in human hypothalamic neurons, and then further in an animal model.” (07:31)

9. Future Research Directions

[07:50] Dr. Schall:

• Next steps include screening additional “puberty genes” and extending zebrafish studies to measure neuronal changes in response to environmental compounds.
• Use of fluorescent transgenic zebrafish to visualize effects on GnRH neuron populations.

Notable Quotes

• Dr. Schall:
  • “It starts in the brain and the hypothalamus.” (02:37)
  • “All of it was surprising because I think no one’s really looked at these receptors and the potential for the environment to interact with them.” (04:37)
  • “We really don’t know [about children’s exposure], and that’s something we need to study next.” (05:52)
  • “Sometimes it’s not even a long exposure, it could be…withdrawal of that exposure is actually what can trigger the system.” (06:46)
  • “The way we approached this problem was really unique…sets up a pipeline that other people could follow.” (07:28)

Key Timestamps

| Timestamp | Segment | Details | |-----------|---------------------------------------|----------------------------------------------| | 01:11 | Earlier puberty in girls | Trend description, suggested causes | | 01:48 | Endocrine-disrupting compounds | Mechanism of action | | 02:20 | Kisspeptin/GnRH focus | Rationale for choosing these targets | | 02:58 | Study methodology | TOX21 10K library, experimental design | | 04:35 | Major findings | Musk ambrette, cholinergic agonists | | 05:36 | Exposure assessment | Prevalence and regulation concerns | | 06:34 | Dose–response/withdrawal effects | Hormonal impact from low or transient doses | | 07:26 | Study significance | Unique pipeline, research implications | | 07:50 | Future research | Plans for further experimentation |

Summary

This episode delivers an accessible yet rich exploration of how everyday environmental chemicals—especially those in fragrances and cosmetics—may directly impact the brain’s initiation of puberty in girls. Leveraging cutting-edge screening methods, Dr. Schall’s team has detected previously unrecognized risks and underscored the crucial need for new research on both exposure levels and health outcomes. Her paradigm-setting approach, moving beyond estrogen and androgen receptors to study brain-specific hormone pathways, opens new avenues for endocrine and public health research.